Early signs of wear in replaced heart valves for aortic stenosis
Scans for early wear of replaced valves in aortic stenosis.
Key facts
- Who runs it
- St. Antonius Hospital
- Where
- Edinburgh, United KingdomSee the siteAlso in 2 other countries, 3 sites
- Trial code
- Registry title
- The Effect of Subclinical Leaflet Thrombosis and Prosthesis Type on Transcatheter Aortic Valve Degeneration (POPular PET TAVI)
- Status
- Recruiting
- People taking part
- 180 people, planned
- Started
- 16 Nov 2023
- Planned end
- 1 Oct 2026
- Type of study
- Observational, 2 groups
- Treatments tested
- 18F-sodium fluoride Positron Emission Tomography (18F-NaF PET), Cardiac Computed Tomography (CT), Transthoracic Echocardiography (TTE)
- Record updated
- 19 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who had a successful TAVI (aortic valve replacement through a catheter) about 5 years ago. It uses scans to look for early signs of valve wear.
- Age
- 18 Years and older
- Sex
- All
- Disease stage
- Aortic valve stenosis (narrowed aortic valve) treated with TAVI about 5 years ago.
- Earlier treatment
- Must have had a successful TAVI with a Sapien or CoreValve Evolut valve about 5 years ago. Cannot have used blood-thinning pills (oral anticoagulation), short or long term, after TAVI.
Main reasons for not taking part
- Use of oral anticoagulation (blood-thinning pills) at any time after TAVI
- Known severe kidney failure
- Known severe leak around the new valve (paravalvular regurgitation)
- A past valve-in-valve procedure
- Any repeat procedure on the aortic valve, including closing a leak around the valve
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Successful TAVI with Sapien or CoreValve Evolut prosthesis about 5 years ago
- Able to undergo hybrid 18F-NaF PET-CT imaging and transthoracic echocardiography
- Written informed consent
Who cannot take part
- Known severe renal insufficiency
- History of valve-in-valve procedure
- History of aortic valve re-intervention (including percutaneous paravalvular leak closure)
- Temporary or chronic oral anticoagulation use after TAVI
- Known severe paravalvular regurgitation
Where in United Kingdom
Also in 2 other countries, 3 sites
- University of EdinburghEdinburgh, United KingdomContact: Prof. M. Dweck, MD, PhDNot yet recruiting
About the trial
What the trial wants to find out
A multicentre cross-sectional cohort study to assess the difference in bioprosthetic micro-calcification activity, detected with 18F-NaF PET-CT, as early marker of transcatheter valve degeneration, between patients with vs. without subclinical leaflet thrombosis at five years after TAVI; and between patients with intra-annular vs. supra-annular TAVI prostheses.
The 2 groups in the trial
- Intra-annular
Patients with an intra-annular Sapien TAVI prosthesis
Treatment: 18F-sodium fluoride Positron Emission Tomography (18F-NaF PET), Cardiac Computed Tomography (CT), Transthoracic Echocardiography (TTE)
- Supra-annular
Patients with a supra-annular CoreValve Evolut TAVI prosthesis
Treatment: 18F-sodium fluoride Positron Emission Tomography (18F-NaF PET), Cardiac Computed Tomography (CT), Transthoracic Echocardiography (TTE)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- The Effect of Subclinical Leaflet Thrombosis and Prosthesis Type on Transcatheter Aortic Valve Degeneration
- Plain-language title
- Early signs of wear in replaced heart valves for aortic stenosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 19 May 2026